List of Veeva Clinical Platform Customers
Pleasanton, 94588, CA,
United States
Since 2010, our global team of researchers has been studying Veeva Clinical Platform customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Veeva Clinical Platform for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Veeva Clinical Platform for Clinical Trial Management include: Amgen, a United States based Life Sciences organisation with 28000 employees and revenues of $33.42 billion, Sarah Cannon Research Institute (SCRI), a United States based Life Sciences organisation with 885 employees and revenues of $180.0 million and many others.
Contact us if you need a completed and verified list of companies using Veeva Clinical Platform, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Veeva Clinical Platform customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Amgen | Life Sciences | 28000 | $33.4B | United States | Veeva Systems | Veeva Clinical Platform | Clinical Trial Management | 2025 | n/a |
In 2025, Amgen will deploy the Veeva Clinical Platform to support its clinical trial operations, establishing the application as a core Clinical Trial Management capability across the organization. The announcement states Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process, and senior leadership emphasized the platforms role in unlocking new capabilities for end-to-end trial operations.
Implementation will focus on Clinical Trial Management functions common to the Clinical Trial Management category, including study setup and study start-up workflows, clinical trial management system orchestration, trial master file and regulatory document lifecycle management, monitoring and site management workflows, and subject enrollment and visit tracking. Configuration will emphasize workflow automation and centralized document control to standardize operational processes across studies.
The deployment is positioned as a cloud-native, enterprise clinical operations platform to be used across Amgens clinical operations, regulatory, monitoring, and study teams, supporting study design through close-out. The collaboration frames the Veeva Clinical Platform as a unified data and process layer for trial oversight and operational orchestration, with the expectation that it will integrate into Amgens broader clinical operations tooling and governance without naming specific third-party systems.
Governance and rollout messaging ties the program to Amgens clinical operations and information leadership, with the companys senior vice president and chief information officer publicly noting the collaboration. Amgen expects the Veeva Clinical Platform deployment to further strengthen its ability to bring innovative treatments to patients with speed and scale, while enabling standardized workflows and tighter operational control across its clinical trial portfolio.
|
 |
Sarah Cannon Research Institute (SCRI) | Life Sciences | 885 | $180M | United States | Veeva Systems | Veeva Clinical Platform | Clinical Trial Management | 2025 | n/a |
In 2025, Sarah Cannon Research Institute adopted Veeva Clinical Platform as its enterprise Clinical Trial Management foundation to centralize oncology study operations across more than 200 research site locations. The announcement names Veeva Systems and SCRI in a strategic collaboration to unify contract research organization and site management organization functions on a single platform for seamless data flow across clinical teams and research sites.
The Veeva Clinical Platform deployment focuses on standardizing study processes and automating key workflows typical of Clinical Trial Management, including study start up and site activation, site management and monitoring workflows, and centralized document and trial oversight. Veeva Clinical Platform is positioned as a connected foundation for clinical research, enabling automation of recurring trial tasks and a streamlined experience for investigators and site staff.
Operational coverage explicitly spans SCRI clinical teams, investigators, its CRO and SMO functions, and all research sites, with the platform serving as the primary Clinical Trial Management system for site-to-sponsor information flow. The project emphasizes unified data flows and standard operating workflows across distributed site locations, improving coordination between research sites and central study teams without specifying third party system integrations.
Governance and rollout are structured around platform standardization and process harmonization, with executive sponsorship from SCRI digital leadership and a vendor collaboration model with Veeva Systems. The collaboration is described as intended to drive speed and efficiency in oncology clinical trials, supporting SCRI in delivering faster and more cost-effective trials while enhancing precision in investigator and clinical team collaboration.
|
Buyer Intent: Companies Evaluating Veeva Clinical Platform
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||